Native ligation process
US-9796758-B2 · Oct 24, 2017 · US
US10072041B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10072041-B2 |
| Application number | US-201213985369-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 15, 2012 |
| Priority date | Feb 16, 2011 |
| Publication date | Sep 11, 2018 |
| Grant date | Sep 11, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Method for preparing a peptide assembly of n fragments and n−1 amino acids bearing a thiol function, represented by the formula: A 1 -C 1 -A 2 -C 2 -A 3 - . . . -C i−1 -A i - . . . -C n−1 -A n (I) in which A 1 , A 2 , A 3 , . . . A i . . . , A n are peptide fragments, C 1 , C 2 , C 3 . . . C i−1 . . . C n−1 are amino acid residues bearing a thiol function, n is comprised between 3 and 50, and i is 2 to n, in which a peptide-thioester is prepared of formula: A 1 -SR (II) in which A 1 is a peptide fragment and SR is an alkyl thioester residue, R being alkyl optionally substituted, starting from a bis(2-sulphanylethyl)amino peptide.
Opening claim text (preview).
The invention claimed is: 1. A method for preparing a peptide assembly of n fragments and n−1 amino acids bearing a thiol moiety, represented by the formula: A 1 -C 1 -A 2 -C 2 -A 3 - . . . -C i−1 -A i - . . . -C n−1 -A n (I) in which A 1 , A 2 , A 3 , . . . A i . . . , A n are peptide fragments, C 1 , C 2 , C 3 . . . C i−1 . . . C n−1 are amino acid residues bearing a thiol moiety, n is comprised between 3 and 50, and i is any integer comprised between 2 and n, the method comprising the steps of treating a bis(2-sulphanylethyl)amino peptide: A 1 -SEAoff in which SEAoff is a cyclic bis(2-sulphanylethyl)amino group with a thiol R—SH, in the presence of a cyclic disulphide reducing agent to prepare a peptide-thioester of formula: A 1 -SR (II) in which A 1 is a peptide fragment and SR is an alkyl thioester residue, R being able to be an optionally substituted alkyl radical, preparing a peptide fragment of formula (IV) by condensing a peptide fragment of structure: H—C 1 (SR′)-A 2 -SEAoff (III) in which C 1 , A 2 and SEAoff are defined as above and (SR′) represents a disulphide residue on the thiol of the amino acid C 1 , with the peptide thioester of formula (II) in the presence of an aromatic thiol ArSH, to obtain the peptide fragment of structure: A 1 -C 1 -A 2 -SEAoff (IV) in which A 1 , C 1 , A 2 and SEAoff are as defined previously, preparing a peptide thioester of formula: A 1 -C 1 -A 2 -SR (II′) in which A 1 , C 1 , A 2 and R are as defined previously, by treating the peptide fragment of formula (IV) with a thiol R—SH, in the presence of a cyclic disulphide reducing agent, preparing a peptide fragment of formula (IV′) by condensing a peptide fragment of structure: H—C 2 (SR′)-A 3 -SEAoff (III′) in which SEAoff and R′ and C 2 and A 3 are defined as above, with the peptide thioester of formula (II′) in the presence of an aromatic thiol (ArSH), in order to produce a peptide fragment of structure: A 1 -C 1 -A 2 -C 2 -A 3 -SEAoff (IV′) in which A 1 , C 1 , A 2 , C 2 , A 3 and SEAoff are as defined previously, and reiterating these 2 operations up to n−2 times, in order to obtain a peptide fragment of structure: A 1 -C 1 -A 2 -C 2 -A 3 - . . . -C i−1 -A i - . . . -C n−2 -A n−1 -SEAoff (IV m ) in which A 1 , A 2 , A 3 , . . . A i . . . , A n−1 , C 1 , C 2 , C 3 . . . C i−1 . . . C n−2 and SEAoff are as defined previously, followed by implementing a native ligation reaction of this obtained peptide fragment (IV m ), with a peptide of formula: H—C n−1 -A n (V n ) in which C n−1 and A n are as defined previously, in the presence of a cyclic disulphide reducing agent, in order to produce the multiple peptide assembly of general formula (I) wherein assembly proceeds from the peptide N-terminal end to the C-terminal end, and wherein a peptide assembly of n fragments is prepared in a “one pot” reaction in the absence of a step of isolating intermediates. 2. A method according to claim 1 , wherein a peptide assembly of 3 or 4 fragments is prepared, of structures A 1 -C 1 -A 2 -C 2 -A 3 or A 1 -C 1 -A 2 -C 2 -A 3 -C 3 -A 4 . 3. A method according to claim 1 , wherein C 1 , C 2 , C 3 . . . C i−1 . . . C n−1 represent Cys residues. 4. A method according to claim 1 , wherein one or more of the peptide fragments A 2 . . . A i . . . A n−1 can bear one or more modified amino acids. 5. A method according to claim 1 , wherein the condensing of the peptide-thioester with a peptide fragment of structure (III) is carried out in the presence of 4-mercaptophenylacetic acid. 6. A method for manufacturing a pharmaceutical composition wherein the method comprises: manufacturing a polypeptide of formula (I) according to claim 1 , and preparing a pharmaceutical composition comprising a polypeptide or peptide thus prepared, in the pure state or in combination with one or more compatible and pharmaceutically acceptable adjuvants. 7. A method for manufacturing a diagnostic device wherein the method comprises: manufacturing a polypeptide of formula (I) according to claim 1 , and preparing a formulation or forming of this polypeptide in a form suitable for use for a diagnostic device. 8. A method according to claim 1 , wherein the cyclic disulphide reducing agent is tris(2-carboxyethyl)phosphine. 9. A method according to claim 1 , wherein n is comprised between 3 and 20. 10. A method according to claim 1 , wherein n is comprised between 3 and 10.
Related publications grouped by family.
Answers are generated from the same data shown on this page.